Experimental group:Saccharomyces boulardii + Amoxicillin + Vonoprazan

2 trials

Sponsors

The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University

Conditions

Helicobacter pylori infection

Phase 4

The effect of Saccharomyces boulardii supplementation on the vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication

RecruitingChiCTR2300075347

The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical UniversityHelicobacter pylori infection

Start: 2023-09-01Updated: 2023-09-04

The effect of Saccharomyces boulardii combined with vonoprazan-based rescue therapy for Helicobacter pylori infection

Active, not recruitingChiCTR2300075382

The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical UniversityHelicobacter pylori infection

Start: 2023-09-04Updated: 2023-09-11

Related Papers

Effects of supplementing with Saccharomyces boulardii on vonoprazan–amoxicillin dual therapy for naive Helicobacter pylori infection: a randomized controlled trial

BMC Gastroenterology2026-04-23